Symptoms & Causes
Introduction
Myxoinflammatory fibroblastic sarcoma (MIFS) is a locally aggressive fibroblastic tumor found in distal extremities, characterized by pleomorphic cells in a myxohyaline matrix and a prominent inflammatory infiltrate.
Reference
WHO Classification of Tumours Editorial Board. Soft tissue and bone tumours [Internet]. Lyon (France): International Agency for Research on Cancer; 2020 [cited 2024 09 11]. (WHO classification of tumours series, 5th ed.; vol. 3). Available from: https://tumourclassification.iarc.who.int/chapters/33.
Related Terminology
Not recommended: inflammatory myxohyaline tumor of the distal extremities with virocyte-like or Reed–Sternberg–like cells; acral myxoinflammatory fibroblastic sarcoma; inflammatory myxoid tumor of the soft parts with bizarre giant cells.
Subtype(s)
None
Symptoms
These neoplasms present as solitary painless masses, typically of the distal extremities. Most examples measure about 3 cm, but the size range is wide. On imaging, they are centered in the subcutis (about two thirds) or deeper and typically display infiltration into adjoining tissues such that they mimic infection, tenosynovial giant cell tumor, or ganglion cysts.
Localization
MIFS usually affects the acral dorsal extremities, particularly the hands, but occasional proximal examples have been highlighted and accounted for about 5% of cases in the largest series to date. The hand, finger, and wrist account for about 60% of cases, and the foot and ankle for about 20%.
Epidemiology
These are rare neoplasms. The reported age range is 4–91 years (median: ~40 years), with no sex predilection.
Etiology
Unknown